The inhibitory mechanism of echinacoside against Staphylococcus aureus Ser/Thr phosphatase Stp1 by virtual screening and molecular modeling

Ronco T, Stegger M, Pedersen K (2017) Draft genome sequence of a sequence type 398 methicillin-resistant Staphylococcus aureus isolate from a Danish dairy cow with mastitis. Microbiol Resour Announc 5:1–2. https://doi.org/10.1128/genomeA.00492-17 Cuny C, Witte W (2017) MRSA in equine hospitals and its significance for infections in humans. Vet Microbiol 200:59–64. https://doi.org/10.1016/j.vetmic.2016.01.013 Paterson GK, Harrison EM, Holmes MA (2014) The emergence of mecC methicillin-resistant Staphylococcus aureus. Trends Microbiol 22:42–47. https://doi.org/10.1016/j.tim.2013.11.003 Sidairi HA, Reid EK, LeBlanc JJ, Sandila N, Head J, Davis I, Bonnar P (2023) Optimizing treatment of Staphylococcus aureus Bloodstream infections following rapid molecular diagnostic testing and an antimicrobial stewardship program intervention. Microbiol Spectr 19:1592–1601. https://doi.org/10.1128/spectrum.01648-22 Kumar G, Kiran Tudu A (2023) Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors. Bioorg Med Chem 80:1–20. https://doi.org/10.1016/j.bmc.2023.117187 Li B, Webster TJ (2018) Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J Orthop Res 36:22–32. https://doi.org/10.1002/jor.23656 Becker K, van Alen S, Idelevich EA, Schleimer N, Seggewiss J, Mellmann A, Kaspar U, Peters G (2018) Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus. Emerg Infect Dis 24:242–248. https://doi.org/10.3201/eid2402.171074 Pichon C, Felden B (2005) Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains. Proc Natl Acad Sci USA 102:14249–14254. https://doi.org/10.1073/pnas.0503838102 David MZ, Daum RS (2010) Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 23:616–687. https://doi.org/10.1128/CMR.00081-09 Scherr TD, Roux CM, Hanke ML, Angle A, Dunman PM, Kielian T (2013) Global transcriptome analysis of Staphylococcus aureus biofilms in response to innate immune cells. Infect Immun 81:4363–4376. https://doi.org/10.1128/iai.00819-13 Shore AC, Deasy EC, Slickers P, Brennan G, O'Connell B, Monecke S, Ehricht R, Coleman DC (2011) Detection of Staphylococcal cassette chromosome mec Type XI carrying highly divergent mecA, mecI, mecR1, blaZ, and ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55:3765–3773. https://doi.org/10.1128/aac.00187-11 Dalal V, Kumari R (2022) Screening and identification of natural product-like compounds as potential antibacterial agents targeting FemC of Staphylococcus aureus: an in-silico approach. ChemistrySelect 7:1–9. https://doi.org/10.1002/slct.202201728 Kumari R, Dalal V (2022) Identification of potential inhibitors for LLM of Staphylococcus aureus: structure-based pharmacophore modeling, molecular dynamics, and binding free energy studies. J Biomol Struct Dyn 40:9833–9847. https://doi.org/10.1080/07391102.2021.1936179 Dalal V, Golemi-Kotra D, Kumar P (2022) Quantum mechanics/molecular mechanics studies on the catalytic mechanism of a novel esterase (FmtA) of Staphylococcus aureus. J Chem Inf Model 62:2409–2420. https://doi.org/10.1021/acs.jcim.2c00057 Dalal V, Kumar P, Rakhaminov G, Qamar A, Fan X, Hunter H, Tomar S, Golemi-Kotra D, Kumar P (2019) Repurposing an ancient protein core structure: structural studies on FmtA, a novel esterase of Staphylococcus aureus. J Mol Biol 431:3107–3123. https://doi.org/10.1016/j.jmb.2019.06.019 Dalal V, Dhankhar P, Singh V, Singh V, Rakhaminov G, Golemi-Kotra D, Kumar P (2021) Structure-based identification of potential drugs against FmtA of Staphylococcus aureus: virtual screening, molecular dynamics, MM-GBSA, and QM/MM. Protein J 40:148–165. https://doi.org/10.1007/s10930-020-09953-6 Kumari R, Rathi R, Pathak SR, Dalal V (2022) Structural-based virtual screening and identification of novel potent antimicrobial compounds against YsxC of Staphylococcus aureus. J Mol Struct 1255:1–11. https://doi.org/10.1016/j.molstruc.2022.132476 Chen F, Di H, Wang Y, Cao Q, Xu B, Zhang X, Yang N, Liu G, Yang CG, Xu Y, Jiang H, Lian F, Zhang N, Li J, Lan L (2016) Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence. Nat Chem Biol 12:174–179. https://doi.org/10.1038/nchembio.2003 Zheng W, Liang Y, Zhao H, Zhang J, Li Z (2015) 5,5 ′-Methylenedisalicylic acid (MDSA) modulates SarA/MgrA phosphorylation by targeting Ser/Thr phosphatase Stp1. Chembiochem 16:1035–1040. https://doi.org/10.1002/cbic.201500003 Burnside K, Lembo A, Harrell MI, Gurney M, Xue L, Nguyen-Thao Binh T, Connelly JE, Jewell KA, Schmidt BZ, de los Reyes M, Tao WA, Doran KS, Rajagopal L (2011) Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus. J Biol Chem 286:44197–44210. https://doi.org/10.1074/jbc.M111.313486 Cameron DR, Ward DV, Kostoulias X, Howden BP, Moellering Jr RC, Eliopoulos GM, Peleg AY (2012) Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J Infect Dis 205:1677–1687. https://doi.org/10.1093/infdis/jis252 Zheng WH, Cai XD, Xie MS, Liang YJ, Wang T, Li ZG (2016) Structure-based identification of a potent inhibitor targeting Stp1-mediated virulence regulation in Staphylococcus aureus. Cell Chem Biol 23:1002–1013. https://doi.org/10.1016/j.chembiol.2016.06.014 Liu T-t, Yang T, Gao M-n, Chen K-x, Yang S, Yu K-q, Jiang H-l (2019) The inhibitory mechanism of aurintricarboxylic acid targeting serine/threonine phosphatase Stp1 in Staphylococcus aureus: insights from molecular dynamics simulations. Acta Pharmacol Sin 40:850–858. https://doi.org/10.1038/s41401-019-0216-x Murthy HN, Kim YS, Park SY, Paek KY (2014) Biotechnological production of caffeic acid derivatives from cell and organ cultures of Echinacea species. Appl Microbiol Biotechnol 98:7707–7717. https://doi.org/10.1007/s00253-014-5962-6 Chen W, Lin H-R, Wei C-M, Luo X-H, Sun M-L, Yang Z-Z, Chen X-Y, Wang H-B (2018) Echinacoside, a phenylethanoid glycoside from Cistanche deserticola, extends lifespan of Caenorhabditis elegans and protects from Aβ-induced toxicity. Biogerontology 19:47–65. https://doi.org/10.1007/s10522-017-9738-0 Xiong WT, Gu L, Wang C, Sun HX, Liu X (2013) Anti-hyperglycemic and hypolipidemic effects of Cistanche tubulosa in type 2 diabetic db/db mice. J Ethnopharmacol 150:935–945. https://doi.org/10.1016/j.jep.2013.09.027 Macková A, Mucaji P, Widowitz U, Bauer R (2013) In vitro anti-inflammatory activity of Ligustrum vulgare extracts and their analytical characterization. Nat Prod Commun 8:1509–1512. https://doi.org/10.1177/1934578X1300801102 Dong L, Yu D, Wu N, Wang H, Niu J, Wang Y, Zou Z (2015) Echinacoside induces apoptosis in human SW480 colorectal cancer cells by induction of oxidative DNA damages. Int J Mol Sci 16:14655–14668. https://doi.org/10.3390/ijms160714655 Chuang HW, Wang TY, Huang CC, Wei IH (2022) Echinacoside exhibits antidepressant-like effects through AMPAR-Akt/ERK-mTOR pathway stimulation and BDNF expression in mice. Chin Med 17:1–12. https://doi.org/10.1186/s13020-021-00549-5 Yang Y, Wang X, Gao Y, Wang H, Niu X (2021) Insight into the dual inhibitory mechanism of verbascoside targeting serine/threonine phosphatase Stp1 against Staphylococcus aureus. Eur J Pharm Sci 157:1–11. https://doi.org/10.1016/j.ejps.2020.105628 Gao YW, Wang HS, Li XN, Niu XD (2023) Molecular mechanism of green tea polyphenol epicatechin gallate attenuating Staphylococcus aureus pathogenicity by targeting Ser/Thr phosphatase Stp1. Food Funct 14:4792–4806. https://doi.org/10.1039/d3fo00170a Song M, Li L, Li M, Cha YH, Deng XM, Wang JF (2016) Apigenin protects mice from pneumococcal pneumonia by inhibiting the cytolytic activity of pneumolysin. Fitoterapia 115:31–36. https://doi.org/10.1016/j.fitote.2016.09.017 Teng Z, Shi D, Liu H, Shen Z, Zha Y, Li W, Deng X, Wang J (2017) Lysionotin attenuates Staphylococcus aureus pathogenicity by inhibiting alpha-toxin expression. Appl Microbiol Biotechnol 101:6697–6703. https://doi.org/10.1007/s00253-017-8417-z Vieira TF, Sousa SF (2019) Comparing AutoDock and Vina in ligand/decoy discrimination for virtual screening. Appl Sci 9:1–18. https://doi.org/10.3390/app9214538 Fuhrmann J, Rurainski A, Lenhof HP, Neumann D (2010) A new Lamarckian genetic algorithm for flexible ligand-receptor docking. J Comput Chem 31:1911–1918. https://doi.org/10.1002/jcc.21478 Zayed MF, Ibrahim SRM, Habib ESE, Hassan MH, Ahmed S, Rateb HS (2019) Design, synthesis, antimicrobial and anti-biofilm evaluation, and molecular docking of newly substituted fluoroquinazolinones. Med Chem 15:659–675. https://doi.org/10.2174/1573406414666181109092944 Wang X, Yang Y, Gao Y, Niu X (2020) Discovery of the novel inhibitor against New Delhi metallo-β-lactamase based on virtual screening and molecular modelling. Int J Mol Sci 21:1–14. https://doi.org/10.3390/ijms21103567 Nhung NT, Duong N, Phung HTT, Vo QV, Tam NM (2022) In silico screening of potential β-secretase (BACE1) inhibitors from VIETHERB database. J Mol Model 28:1–10. https://doi.org/10.1007/s00894-022-05051-9 Panteva MT, Giambasu GM, York DM (2015) Force field for Mg2+, Mn2+, Zn2+, and Cd2+ ions that have balanced interactions with nucleic acids. J Phys Chem B 119:15460–15470. https://doi.org/10.1021/acs.jpcb.5b10423 Zarezade V, Abolghasemi M, Rahim F, Veisi A, Behbahani M (2018) In silico assessment of new progesterone receptor inhibitors using molecular dynamics: a new insight into breast cancer treatment. J Mol Model 24:1–19. https://doi.org/10.1007/s00894-018-3858-6 Eftink MR, Ghiron CA (1981) Fluorescence quenching studies with proteins. Anal Biochem 114:199–227. https://doi.org/10.1016/0003-2697(81)90474-7 Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:1–13. https://doi.org/10.1038/srep42717 Çalışkaner ZO (2022) Computational discovery of novel inhibitory candidates targeting versatile transcriptional repressor MBD2. J Mol Model 28:1–17. https://doi.org/10.1007/s00894-022-05297-3 Singh V, Dhankhar P, Dalal V, Tomar S, Golemi-Kotra D, Kumar P (2022) Drug-repurposing approach to combat Staphylococcus aureus: biomolecular and binding interaction study. ACS Omega 7:38448–38458. https://doi.org/10.1021/acsomega.2c03671 Yang T, Liu T, Gan J, Yu K, Chen K, Xue W, Lan L, Yang S, Yang C-G (2019) Structural insight into the mechanism of Staphylococcus aureus Stp1 phosphatase. ACS Infect Dis 5:841–850. https://doi.org/10.1021/acsinfecdis.8b00316 Liu J, Yang L, Dong Y, Zhang B, Ma X (2018) Echinacoside, an inestimable natural product in treatment of neurological and other disorders. Molecules 23:1–23. https://doi.org/10.3390/molecules23051213 Li F, Yang X, Yang Y, Li P, Yang Z, Zhang C (2015) Phospholipid complex as an approach for bioavailability enhancement of echinacoside. Drug Dev Ind Pharm 41:1777–1784. https://doi.org/10.3109/03639045.2015.1004183 Shen JY, Yang XL, Yang ZL, Kou JP, Li F (2015) Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil. Drug Des Devel Ther 9:4685–4693. https://doi.org/10.2147/dddt.s87581 Yang X, Li F, Yang Y, Shen J, Zou R, Zhu P, Zhang C, Yang Z, Li P (2013) Efficacy and safety of echinacoside in a rat osteopenia model. Evid Based Complement Alternat Med 2013:1–11. https://doi.org/10.1155/2013/926928 Wu Y, Li L, Wen T, Li Y-Q (2007) Protective effects of echinacoside on carbon tetrachloride-induced hepatotoxicity in rats. Toxicology 232:50–56. https://doi.org/10.1016/j.tox.2006.12.013